Evaluation of a Novel Continuous Glucose Monitoring-Based Method for Mealtime Insulin Dosing—the <i>iBolus</i> —in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Controlled Trial

Abstract

A CGM-based algorithm for calculation of prandial insulin is feasible, although it does not reduce unpredictability of individual glycemic responses. Causes of variability need to be identified and analyzed for further optimization of postprandial glycemic control.